Ivan Molano

744 total citations
19 papers, 617 citations indexed

About

Ivan Molano is a scholar working on Immunology, Rheumatology and Cancer Research. According to data from OpenAlex, Ivan Molano has authored 19 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 11 papers in Rheumatology and 4 papers in Cancer Research. Recurrent topics in Ivan Molano's work include Systemic Lupus Erythematosus Research (11 papers), T-cell and B-cell Immunology (5 papers) and Immune Cell Function and Interaction (5 papers). Ivan Molano is often cited by papers focused on Systemic Lupus Erythematosus Research (11 papers), T-cell and B-cell Immunology (5 papers) and Immune Cell Function and Interaction (5 papers). Ivan Molano collaborates with scholars based in United States, China and South Korea. Ivan Molano's co-authors include Gary S. Gilkeson, Titus A. Reaves, Louis Terracio, Thomas K. Borg, Wayne Carver, Philip Ruiz, Phillip Ruiz, Lingyun Sun, Dennis K. Watson and Fei Gu and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Ivan Molano

19 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivan Molano United States 12 319 201 153 95 83 19 617
Celia M. Longhurst United States 13 291 0.9× 185 0.9× 168 1.1× 63 0.7× 54 0.7× 16 836
Sook Kyung Chang United States 11 642 2.0× 175 0.9× 319 2.1× 271 2.9× 51 0.6× 13 1.1k
Ante Jelaska United States 8 226 0.7× 76 0.4× 218 1.4× 48 0.5× 67 0.8× 8 659
Tiina Hurskainen Finland 11 94 0.3× 117 0.6× 143 0.9× 80 0.8× 112 1.3× 14 557
Dennis F.G. Remst Netherlands 12 161 0.5× 388 1.9× 377 2.5× 237 2.5× 38 0.5× 25 817
James N. Wygant United States 14 122 0.4× 314 1.6× 407 2.7× 138 1.5× 36 0.4× 14 778
Hidenori Hase Japan 13 481 1.5× 81 0.4× 197 1.3× 118 1.2× 52 0.6× 17 750
John P. Seery United Kingdom 12 269 0.8× 126 0.6× 215 1.4× 139 1.5× 18 0.2× 16 710
Laurent Drouot France 17 229 0.7× 254 1.3× 337 2.2× 37 0.4× 129 1.6× 28 990
B N Franklin Germany 4 184 0.6× 385 1.9× 224 1.5× 190 2.0× 34 0.4× 5 711

Countries citing papers authored by Ivan Molano

Since Specialization
Citations

This map shows the geographic impact of Ivan Molano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Molano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Molano more than expected).

Fields of papers citing papers by Ivan Molano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan Molano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Molano. The network helps show where Ivan Molano may publish in the future.

Co-authorship network of co-authors of Ivan Molano

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan Molano. A scholar is included among the top collaborators of Ivan Molano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan Molano. Ivan Molano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Geng, Linyu, Jian Zhao, Yun Deng, et al.. (2021). Human SLE variant NCF1-R90H promotes kidney damage and murine lupus through enhanced Tfh2 responses induced by defective efferocytosis of macrophages. Annals of the Rheumatic Diseases. 81(2). 255–267. 31 indexed citations
3.
Geng, Linyu, Yun Deng, Ivan Molano, et al.. (2021). 1506 A human SLE variant NCF1-R90H promotes kidney damage and murine lupus through enhanced Tfh2 responses induced by defective efferocytosis of macrophages. SHILAP Revista de lepidopterología. A65.1–A65. 1 indexed citations
4.
Molano, Ivan, et al.. (2020). TLR7 Agonism Accelerates Disease and Causes a Fatal Myeloproliferative Disorder in NZM 2410 Lupus Mice. Frontiers in Immunology. 10. 3054–3054. 9 indexed citations
5.
Nowling, Tamara K., Thirumagal Thiyagarajan, Bethany J. Wolf, et al.. (2020). Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice. PLoS ONE. 15(3). e0230499–e0230499. 14 indexed citations
6.
Sundararaj, Kamala, Thirumagal Thiyagarajan, Ivan Molano, et al.. (2015). FLI1 Levels Impact CXCR3 Expression and Renal Infiltration of T Cells and Renal Glycosphingolipid Metabolism in the MRL/lpr Lupus Mouse Strain. The Journal of Immunology. 195(12). 5551–5560. 25 indexed citations
7.
Gu, Fei, Maosong Qi, Ivan Molano, et al.. (2014). Differential Efficacy of Human Mesenchymal Stem Cells Based on Source of Origin. The Journal of Immunology. 193(9). 4381–4390. 46 indexed citations
8.
Dasgupta, Subhajit, Ivan Molano, Mausumi Bandyopadhyay, & Mark S. Kindy. (2012). Lipoteichoic acid induces B cell activation in female MRL/lpr (fas) mice: implications for lupus cerebritis (159.6). The Journal of Immunology. 188(1_Supplement). 159.6–159.6. 1 indexed citations
9.
Gu, Fei, Ivan Molano, Philip Ruiz, Lingyun Sun, & Gary S. Gilkeson. (2012). Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice. Clinical Immunology. 145(2). 142–152. 47 indexed citations
10.
Dasgupta, Subhajit & Ivan Molano. (2012). Specific antigenic recognition shifts a balance from tolerance to effector immune responses in lupus cerebritis (173.34). The Journal of Immunology. 188(1_Supplement). 173.34–173.34. 1 indexed citations
11.
Williams, Sarah, et al.. (2010). Impact of Fli-1 transcription factor on autoantibody and lupus nephritis in NZM2410 mice. Clinical & Experimental Immunology. 162(2). 362–371. 33 indexed citations
12.
13.
Moussa, Omar, Amanda C. LaRue, Ivan Molano, et al.. (2008). The Transcription Factor Fli-1 Modulates Marginal Zone and Follicular B Cell Development in Mice. The Journal of Immunology. 181(3). 1644–1654. 54 indexed citations
14.
Molano, Ivan, Omar Moussa, Phillip Ruiz, et al.. (2004). Decreased Expression of the Ets Family Transcription Factor Fli-1 Markedly Prolongs Survival and Significantly Reduces Renal Disease in MRL/ lpr Mice. The Journal of Immunology. 173(10). 6481–6489. 56 indexed citations
15.
Molano, Ivan, Hideharu Sekine, Christopher M. Reilly, et al.. (2003). Effect of genetic deficiency of terminal deoxynucleotidyl transferase on autoantibody production and renal disease in MRL/lpr mice. Clinical Immunology. 107(3). 186–197. 11 indexed citations
16.
Oates, Jim C., Marc C. Levesque, Maurine R. Hobbs, et al.. (2003). Nitric oxide synthase 2 promoter polymorphisms and systemic lupus erythematosus in african-americans.. PubMed. 30(1). 60–7. 34 indexed citations
17.
Sekine, Hideharu, Christopher M. Reilly, Ivan Molano, et al.. (2001). Complement Component C3 Is Not Required for Full Expression of Immune Complex Glomerulonephritis in MRL/ lpr Mice. The Journal of Immunology. 166(10). 6444–6451. 114 indexed citations
18.
Molano, Ivan, Mary K. Wloch, Audrey Alexander, Hiroshi Watanabe, & Gary S. Gilkeson. (2000). Effect of a Genetic Deficiency of Terminal Deoxynucleotidyl Transferase on Autoantibody Production by C57BL6 Faslpr Mice. Clinical Immunology. 94(1). 24–32. 9 indexed citations
19.
Carver, Wayne, Ivan Molano, Titus A. Reaves, Thomas K. Borg, & Louis Terracio. (1995). Role of the α1β1 integrin complex in collagen gel contraction in vitro by fibroblasts. Journal of Cellular Physiology. 165(2). 425–437. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Celia M. Longhurst Breakdown of academic impact, for papers by Sook Kyung Chang Breakdown of academic impact, for papers by Ante Jelaska Breakdown of academic impact, for papers by Tiina Hurskainen Breakdown of academic impact, for papers by Dennis F.G. Remst Breakdown of academic impact, for papers by James N. Wygant Breakdown of academic impact, for papers by Hidenori Hase Breakdown of academic impact, for papers by John P. Seery Breakdown of academic impact, for papers by Laurent Drouot Breakdown of academic impact, for papers by B N Franklin
Rankless by CCL
2026